Skip to main content
Erschienen in: neurogenetics 2/2004

01.06.2004 | Original Article

Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16

verfasst von: Luc Djoussé, Beth Knowlton, Michael R. Hayden, Elisabeth W. Almqvist, Ryan R. Brinkman, Christopher A. Ross, Russel L. Margolis, Adam Rosenblatt, Alexandra Durr, Catherine Dode, Patrick J. Morrison, Andrea Novelletto, Marina Frontali, Ronald J. A. Trent, Elizabeth McCusker, Estrella Gómez-Tortosa, David Mayo Cabrero, Randi Jones, Andrea Zanko, Martha Nance, Ruth K. Abramson, Oksana Suchowersky, Jane S. Paulsen, Madaline B. Harrison, Qiong Yang, L. Adrienne Cupples, Jayalakshmi Mysore, James F. Gusella, Marcy E. MacDonald, Richard H. Myers

Erschienen in: Neurogenetics | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract.

Huntington disease (HD) is a neurodegenerative disorder caused by the abnormal expansion of CAG repeats in the HD gene on chromosome 4p16.3. A recent genome scan for genetic modifiers of age at onset of motor symptoms (AO) in HD suggests that one modifier may reside in the region close to the HD gene itself. We used data from 535 HD participants of the New England Huntington cohort and the HD MAPS cohort to assess whether AO was influenced by any of the three markers in the 4p16 region: MSX1 (Drosophila homeo box homologue 1, formerly known as homeo box 7, HOX7), Δ2642 (within the HD coding sequence), and BJ56 (D4S127). Suggestive evidence for an association was seen between MSX1 alleles and AO, after adjustment for normal CAG repeat, expanded repeat, and their product term (model P value 0.079). Of the variance of AO that was not accounted for by HD and normal CAG repeats, 0.8% could be attributed to the MSX1 genotype. Individuals with MSX1 genotype 3/3 tended to have younger AO. No association was found between Δ2642 (P=0.44) and BJ56 (P=0.73) and AO. This study supports previous studies suggesting that there may be a significant genetic modifier for AO in HD in the 4p16 region. Furthermore, the modifier may be present on both HD and normal chromosomes bearing the 3 allele of the MSX1 marker.
Literatur
1.
Zurück zum Zitat Huntington G (1872) On chorea. Med Surg Rep 26:320–321 Huntington G (1872) On chorea. Med Surg Rep 26:320–321
2.
Zurück zum Zitat Hayden MR, Berkowicz AL, Beighton PH, Yiptong C (1981) Huntington’s chorea on the island of Mauritius. S Afr Med J 60:1001–1002PubMed Hayden MR, Berkowicz AL, Beighton PH, Yiptong C (1981) Huntington’s chorea on the island of Mauritius. S Afr Med J 60:1001–1002PubMed
3.
Zurück zum Zitat Folstein SE (1989) Huntington’s disease: a disorder of families. The Johns Hopkins University Press, Baltimore Folstein SE (1989) Huntington’s disease: a disorder of families. The Johns Hopkins University Press, Baltimore
4.
Zurück zum Zitat White RF, Vasterling JJ, Koroshetz W, Myers RH (1992) Neuropsychology of Huntington’s disease. In: White RF (ed) Clinical syndromes in adult neuropsychology: the practioners handbook. , Elsevier, New York, pp 213–251 White RF, Vasterling JJ, Koroshetz W, Myers RH (1992) Neuropsychology of Huntington’s disease. In: White RF (ed) Clinical syndromes in adult neuropsychology: the practioners handbook. , Elsevier, New York, pp 213–251
5.
Zurück zum Zitat Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306:234–238PubMed Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306:234–238PubMed
6.
Zurück zum Zitat Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 79:971–983 Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 79:971–983
7.
Zurück zum Zitat Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Conneally P, Young A, Penney J, Hollingsworth Z, Shoulson I, Lazzarini A, Falek A, Koroshetz W, Sax D, Bird E, Vonsattel J, Bonilla E, Alvir J, Conde JB, Cha JH, Dure L, Gomez F, Ramos M, Sanchezramos J, Snodgrass S, Deyoung M, Wexler N, Moscowitz C, Penchaszadeh G, Macfarlane H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella J, Macdonald M (1993) Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat Genet 4:387–392PubMed Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Conneally P, Young A, Penney J, Hollingsworth Z, Shoulson I, Lazzarini A, Falek A, Koroshetz W, Sax D, Bird E, Vonsattel J, Bonilla E, Alvir J, Conde JB, Cha JH, Dure L, Gomez F, Ramos M, Sanchezramos J, Snodgrass S, Deyoung M, Wexler N, Moscowitz C, Penchaszadeh G, Macfarlane H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella J, Macdonald M (1993) Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat Genet 4:387–392PubMed
8.
Zurück zum Zitat Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet 4:393–397PubMed Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet 4:393–397PubMed
9.
Zurück zum Zitat Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, Kasch LM, Ghaffari M, Chase GA, Kazazian HH, Brandt J, Folstein SE, Ross CA (1995) Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 57:593–602PubMed Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, Kasch LM, Ghaffari M, Chase GA, Kazazian HH, Brandt J, Folstein SE, Ross CA (1995) Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 57:593–602PubMed
10.
Zurück zum Zitat Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR (1997) The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 60:1202–1210PubMed Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR (1997) The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 60:1202–1210PubMed
11.
Zurück zum Zitat Farrer LA, Cupples LA, Wiater P, Conneally PM, Gusella JF, Myers RH (1993) The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD. Am J Hum Genet 53:125–130PubMed Farrer LA, Cupples LA, Wiater P, Conneally PM, Gusella JF, Myers RH (1993) The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD. Am J Hum Genet 53:125–130PubMed
12.
Zurück zum Zitat Li J, Hayden MR, Almqvist EW, Brinkman RR, Durr A, Dode C, Morrison PJ, Sudo H, Ross CA, Margolis RL, Rosenblatt A, Gomez-Tortosa E, Cabrero DM, Novelletto A, Frontali M, Nance M, Trent RJ, McCusker E, Jones R, Paulsen JS, Harrison M, Zanko A, Abramson RK, Russ AL, Djousse L, Mysore JS, Tariot S, Gusella MF, Wheeler VC, Atwood LD, Cupples LA, Saint-Hilaire M, Cha JH, Hersch SM, Koroshetz WJ, Gusella JF, MacDonald ME, Myers RH (2003) A genome scan for modifiers of age at onset in Huntington’s disease: The HD MAPS Study. Am J Hum Genet 73:682–687CrossRefPubMed Li J, Hayden MR, Almqvist EW, Brinkman RR, Durr A, Dode C, Morrison PJ, Sudo H, Ross CA, Margolis RL, Rosenblatt A, Gomez-Tortosa E, Cabrero DM, Novelletto A, Frontali M, Nance M, Trent RJ, McCusker E, Jones R, Paulsen JS, Harrison M, Zanko A, Abramson RK, Russ AL, Djousse L, Mysore JS, Tariot S, Gusella MF, Wheeler VC, Atwood LD, Cupples LA, Saint-Hilaire M, Cha JH, Hersch SM, Koroshetz WJ, Gusella JF, MacDonald ME, Myers RH (2003) A genome scan for modifiers of age at onset in Huntington’s disease: The HD MAPS Study. Am J Hum Genet 73:682–687CrossRefPubMed
13.
Zurück zum Zitat Ambrose CM, Duyao MP, Barnes G, Bates GP, Lin CS, Srinidhi J, Baxendale S, Hummerich H, Lehrach H, Altherr M, Wasmuth J, Buckler A, Church D, Housman D, Berks M, Micklem G, Durbin R, Dodge A, Read A, Gusella J, Macdonald ME (1994) Structure and expression of the Huntington’s disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 20:27–38PubMed Ambrose CM, Duyao MP, Barnes G, Bates GP, Lin CS, Srinidhi J, Baxendale S, Hummerich H, Lehrach H, Altherr M, Wasmuth J, Buckler A, Church D, Housman D, Berks M, Micklem G, Durbin R, Dodge A, Read A, Gusella J, Macdonald ME (1994) Structure and expression of the Huntington’s disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 20:27–38PubMed
14.
Zurück zum Zitat Taylor SA, Barnes GT, MacDonald ME, Gusella JF (1992) A dinucleotide repeat polymorphism at the D4S127 locus. Hum Mol Genet 1:142 Taylor SA, Barnes GT, MacDonald ME, Gusella JF (1992) A dinucleotide repeat polymorphism at the D4S127 locus. Hum Mol Genet 1:142
15.
Zurück zum Zitat Ivens A, Flavin N, Williamson R, Dixon M, Bates G, Buckingham M, Robert B (1990) The human homeobox gene HOX7 maps to chromosome 4p16.1 and may be implicated in Wolf-Hirschhorn syndrome. Hum Genet 84:473–476PubMed Ivens A, Flavin N, Williamson R, Dixon M, Bates G, Buckingham M, Robert B (1990) The human homeobox gene HOX7 maps to chromosome 4p16.1 and may be implicated in Wolf-Hirschhorn syndrome. Hum Genet 84:473–476PubMed
16.
Zurück zum Zitat Djousse L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C, Margolis R, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, Gomez-Tortosa E, Mayo D, Jones R, Zanko A, Nance M, Abramson R, Suchowersky O, Paulsen J, Harrison M, Yang Q, Cupples LA, Gusella JF, MacDonald ME, Myers RH (2003) Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet 119A:279–282CrossRefPubMed Djousse L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C, Margolis R, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, Gomez-Tortosa E, Mayo D, Jones R, Zanko A, Nance M, Abramson R, Suchowersky O, Paulsen J, Harrison M, Yang Q, Cupples LA, Gusella JF, MacDonald ME, Myers RH (2003) Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet 119A:279–282CrossRefPubMed
17.
Zurück zum Zitat MacDonald ME, Novelletto A, Lin C, Tagle D, Barnes G, Bates G, Taylor S, Allitto B, Altherr M, Myers R, Lehrach H, Collins FS, Wasmuth JJ, Frontali M, Gusella JF (1992) The Huntington’s disease candidate region exhibits many different haplotypes. Nat Genet 1:99–103PubMed MacDonald ME, Novelletto A, Lin C, Tagle D, Barnes G, Bates G, Taylor S, Allitto B, Altherr M, Myers R, Lehrach H, Collins FS, Wasmuth JJ, Frontali M, Gusella JF (1992) The Huntington’s disease candidate region exhibits many different haplotypes. Nat Genet 1:99–103PubMed
18.
Zurück zum Zitat Myers RH, Madden JJ, Teague JL, Falek A (1982) Factors related to onset age of Huntington disease. Am J Hum Genet 34:481–488PubMed Myers RH, Madden JJ, Teague JL, Falek A (1982) Factors related to onset age of Huntington disease. Am J Hum Genet 34:481–488PubMed
19.
Zurück zum Zitat Conneally PM (1984) Huntington disease: genetics and epidemiology. Am J Hum Genet 36:506–526PubMed Conneally PM (1984) Huntington disease: genetics and epidemiology. Am J Hum Genet 36:506–526PubMed
20.
Zurück zum Zitat Farrer LA, Conneally PM (1987) Predictability of phenotype in Huntington’s disease. Arch Neurol. 44:109–113 Farrer LA, Conneally PM (1987) Predictability of phenotype in Huntington’s disease. Arch Neurol. 44:109–113
21.
Zurück zum Zitat Barron LH, Warner JP, Porteous M, Holloway S, Simpson S, Davidson R, Brock DJ (1993) A study of the Huntington’s disease associated trinucleotide repeat in the Scottish population. J Med Genet 30:1003–1007PubMed Barron LH, Warner JP, Porteous M, Holloway S, Simpson S, Davidson R, Brock DJ (1993) A study of the Huntington’s disease associated trinucleotide repeat in the Scottish population. J Med Genet 30:1003–1007PubMed
22.
Zurück zum Zitat Zuhlke C, Riess O, Schroder K, Siedlaczck I, Epplen JT, Engel W, Thies U (1993) Expansion of the (CAG)n repeat causing Huntington’s disease in 352 patients of German origin. Hum Mol Genet 2:1467–1469PubMed Zuhlke C, Riess O, Schroder K, Siedlaczck I, Epplen JT, Engel W, Thies U (1993) Expansion of the (CAG)n repeat causing Huntington’s disease in 352 patients of German origin. Hum Mol Genet 2:1467–1469PubMed
23.
Zurück zum Zitat Myers RH, Marans K, MacDonald ME (1998) Huntington’s disease. In: Warren ST, Wells RT (eds) Genetic instabilities and hereditary neurological diseases. Academic Press, pp 301–323 Myers RH, Marans K, MacDonald ME (1998) Huntington’s disease. In: Warren ST, Wells RT (eds) Genetic instabilities and hereditary neurological diseases. Academic Press, pp 301–323
24.
Zurück zum Zitat Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D (1997) Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A 94:3872–3876CrossRefPubMed Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D (1997) Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A 94:3872–3876CrossRefPubMed
25.
Zurück zum Zitat MacDonald ME, Vonsattel JP, Shrinidhi J, Couropmitree NN, Cupples LA, Bird ED, Gusella JF, Myers RH (1999) Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease. Neurology 53:1330–1332PubMed MacDonald ME, Vonsattel JP, Shrinidhi J, Couropmitree NN, Cupples LA, Bird ED, Gusella JF, Myers RH (1999) Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease. Neurology 53:1330–1332PubMed
26.
Zurück zum Zitat Hewitt JE, Clark LN, Ivens A, Williamson R (1991) Structure and sequence of the human homeobox gene HOX7. Genomics 11:670–678PubMed Hewitt JE, Clark LN, Ivens A, Williamson R (1991) Structure and sequence of the human homeobox gene HOX7. Genomics 11:670–678PubMed
27.
Zurück zum Zitat Ingham PW (1988) The molecular genetics of embryonic pattern formation in Drosophila. Nature 335:25–34CrossRefPubMed Ingham PW (1988) The molecular genetics of embryonic pattern formation in Drosophila. Nature 335:25–34CrossRefPubMed
28.
Zurück zum Zitat Gehring WJ (1987) Homeo boxes in the study of development. Science 236:1245–1252PubMed Gehring WJ (1987) Homeo boxes in the study of development. Science 236:1245–1252PubMed
29.
Zurück zum Zitat Slack JM (1985) Homoeotic transformations in man: implications for the mechanism of embryonic development and for the organization of epithelia. J Theor Biol 114:463–490PubMed Slack JM (1985) Homoeotic transformations in man: implications for the mechanism of embryonic development and for the organization of epithelia. J Theor Biol 114:463–490PubMed
30.
Zurück zum Zitat Jumlongras D, Bei M, Stimson JM, Wang WF, DePalma SR, Seidman CE, Felbor U, Maas R, Seidman JG, Olsen BR (2001) A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet 69:67–74CrossRefPubMed Jumlongras D, Bei M, Stimson JM, Wang WF, DePalma SR, Seidman CE, Felbor U, Maas R, Seidman JG, Olsen BR (2001) A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet 69:67–74CrossRefPubMed
31.
Zurück zum Zitat Lidral AC, Reising BC (2002) The role of MSX1 in human tooth agenesis. J Dent Res 81:274–278PubMed Lidral AC, Reising BC (2002) The role of MSX1 in human tooth agenesis. J Dent Res 81:274–278PubMed
32.
Zurück zum Zitat Almqvist E, Spence N, Nichol K, Andrew SE, Vesa J, Peltonen L, Anvret M, Goto J, Kanazawa I, Goldberg YP, Hayden MR (1995) Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum Mol Genet 4:207–214PubMed Almqvist E, Spence N, Nichol K, Andrew SE, Vesa J, Peltonen L, Anvret M, Goto J, Kanazawa I, Goldberg YP, Hayden MR (1995) Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum Mol Genet 4:207–214PubMed
33.
Zurück zum Zitat Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F, Squitieri F, Campanella G, Bozza A, MacDonald ME, Gusella JF, Frontali M (1994) Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease. Hum Mol Genet 3:1129–1132PubMed Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F, Squitieri F, Campanella G, Bozza A, MacDonald ME, Gusella JF, Frontali M (1994) Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease. Hum Mol Genet 3:1129–1132PubMed
34.
Zurück zum Zitat Lucotte G, Gerard N, Roubertoux P, Schmitt I, Riess O (1996) Relationships of the 2642 deletion polymorphism (delta 2642) in the huntingtin gene with the CAG repeat expansion length and age at onset of the disease. Genet Couns 7:297–302PubMed Lucotte G, Gerard N, Roubertoux P, Schmitt I, Riess O (1996) Relationships of the 2642 deletion polymorphism (delta 2642) in the huntingtin gene with the CAG repeat expansion length and age at onset of the disease. Genet Couns 7:297–302PubMed
Metadaten
Titel
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16
verfasst von
Luc Djoussé
Beth Knowlton
Michael R. Hayden
Elisabeth W. Almqvist
Ryan R. Brinkman
Christopher A. Ross
Russel L. Margolis
Adam Rosenblatt
Alexandra Durr
Catherine Dode
Patrick J. Morrison
Andrea Novelletto
Marina Frontali
Ronald J. A. Trent
Elizabeth McCusker
Estrella Gómez-Tortosa
David Mayo Cabrero
Randi Jones
Andrea Zanko
Martha Nance
Ruth K. Abramson
Oksana Suchowersky
Jane S. Paulsen
Madaline B. Harrison
Qiong Yang
L. Adrienne Cupples
Jayalakshmi Mysore
James F. Gusella
Marcy E. MacDonald
Richard H. Myers
Publikationsdatum
01.06.2004
Verlag
Springer-Verlag
Erschienen in
Neurogenetics / Ausgabe 2/2004
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-004-0175-2

Weitere Artikel der Ausgabe 2/2004

neurogenetics 2/2004 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.